Abstract

Photodynamic therapy (PDT) is a promising treatment in cancer therapy, with a photosensitizer activated by visible light. Aloe‐emodin (AE) is a promising photosensitive agent. In this study, the photosensitizing effects and possible mechanisms of AE‐PDT in MG63 cells were evaluated. The efficiency of AE‐PDT was analyzed by MTT assay. The mode of cell death was investigated by Hoechst 33,342 staining and flow cytometer. The intracellular distribution of AE was detected with confocal microscopy. The formation of reactive oxygen species (ROS) was detected by DCFH‐DA. The mitochondrial membrane potential (MMP) was measured by Rhodamine 123. The expression of proteins including cytochrome c, caspase‐3, ‐9, and ‐12, CHOP and GRP78 was detected by western blot. Apoptosis is the primary mode of cell death in our study, which occurs in a manner of depending on AE concentration and irradiation dose. Confocal microscopy showed that AE was primarily localized on the mitochondria and endoplasmic reticulum (ER) of MG63 cells. AE‐PDT resulted in rapid increases of intracellular ROS production, which reached a peak at 2 h, followed by declining of mitochondrial membrane potential, releasing of cytochrome c from mitochondria into the cytoplasm, and up‐regulation of caspase‐3, ‐9, and ‐12, CHOP and GRP78. These results suggest that death of MG63 cells induced by AE‐PDT is triggered by ROS. Meanwhile, Mitochondria and ER serve as the subcellular targets, which are responsible for AE‐PDT‐induced death of MG63 cells.

Highlights

  • Osteosarcoma is one of the most common malignant tumors of the bone [1]

  • MG63 cells were obtained from the American Type Culture Collection (ATCC) and cultured in DMEM supplemented with 10% Fetal bovine serum (FBS) and antibiotics

  • Apoptosis and necrosis of MG63 cells induced by AE-­Photodynamic therapy (PDT)

Read more

Summary

Introduction

Osteosarcoma is one of the most common malignant tumors of the bone [1]. Radiotherapy, and high-­ dose chemotherapy have improved survival rate over the past several decades [2]. The 5-y­ ear survival rates are still no more than 60%. Drug resistance and occurrence of second malignancies remain serious problems [3]. There is an urgent requirement to develop novel approaches to deal with osteosarcoma [4].

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call